Bolt Biotherapeutics Inc COM

Bolt Biotherapeutics Inc COM is a security (CUSIP 097702203) tracked across SEC portfolio filings. 24 institutional managers reported $2.5M on Form 13F as of 2026-06-30; 2 registered fund positions totaling $29K via N-PORT as of 2026-05-29.

Summary

Top institutional holders (Form 13F)

Showing 15 of 24 managers by value.

ManagerLocationValueShares
Sofinnova Investments, Inc.Menlo Park, CA$556K137,721
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$312K77,225
Vivo Capital, LLCPalo Alto, CA$293K72,414
Pivotal bioVenture Partners Investment Advisor LLCSAN FRANCISCO, CA$172K42,581
T3 Companies, LLCNEW YORK, NY$146K38,000
Board of Trustees of The Leland Stanford Junior UniversitySTANFORD, CA$145K35,977
Pfizer IncNew York, NY$137K31,305
Lynx1 Capital Management LPSAN JUAN, PR$124K30,800
Nan Fung Group Holdings LtdCENTRAL, K3$118K29,250
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$116K28,791
NANO CAP NEW MILLENNIUM GROWTH FUND L PSTATEN ISLAND, NY$111K27,500
Shay Capital LLCNew York, NY$60K14,905
VANGUARD GROUP INCValley Forge, PA$56K10,179
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$47K11,657
CITADEL ADVISORS LLCMIAMI, FL$41K10,109

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$29K0.00%
Guggenheim Active Allocation FundGuggenheim Active Allocation Fund$320.00%

More